A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

Clinical trial NCT05557409 · COMPLETED

Trial details

NCT number: NCT05557409
Sponsor: Axsome Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Agitation in Patients With Dementia of the Alzheimer's Type Alzheimer Disease Agitation

Start date: 2022-09-06
Primary completion: 2024-11-21
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.